Your account is not claimed yet. You can sign up with ORCID to claim your account.

Eva Dombi

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Venues

Neuro-oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Neuro-oncology advances

Cancer research

National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute

United States

Senior Research Assistant :: Pediatric Oncology Branch

Publications

Srivandana Akshintala, R Taylor Sundby, Donna B Bernstein, John W Glod, Rosandra N Kaplan, Marielle E Yohe, Andrea M Gross, Joanne Derdak, Haiyan Lei, Alexander Pan, Eva Dombi, Isabel Palacio-Yance, Kailey R Herrera, Markku M Miettinen, Helen X Chen, Seth M Steinberg, Lee J Helman, Leo Mascarenhas, Brigitte C Widemann, Fariba Navid, Jack F Shern, Christine M Heske
Phase I trial of ganitumab plus dasatinib to cotarget the insulin-like growth factor 1 receptor and Src family kinase YES in rhabdomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Andrea M Gross, Eva Dombi, Pamela L Wolters, Andrea Baldwin, Anne Dufek, Kailey Herrera, Staci Martin, Joanne Derdak, Kara S Heisey, Patricia M Whitcomb, Seth M Steinberg, David J Venzon, Michael J Fisher, Ae Rang Kim, Miriam Bornhorst, Brian D Weiss, Jaishri O Blakely, Malcolm A Smith, Brigitte C Widemann
Long-Term Safety and Efficacy of Selumetinib in Children with Neurofibromatosis Type 1 on a Phase 1/2 Trial for Inoperable Plexiform Neurofibromas. Neuro-oncology (2023)
Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, Jaishri O Blakely, Gideon Bollag, Ashley Cannon, Eva Dombi, Jason Fangusaro, Bruce D Gelb, Darren Hargrave, Ae Rang Kim, Laura J Klesse, Mignon Loh, Staci Martin, Christopher Moertel, Roger Packer, Jonathan M Payne, Katherine A Rauen, Jonathan J Rios, Nathan Robison, Elizabeth K Schorry, Kevin Shannon, David A Stevenson, Elliot Stieglitz, Nicole J Ullrich, Karin S Walsh, Brian D Weiss, Pamela L Wolters, Kaleb Yohay, Marielle E Yohe, Brigitte C Widemann, Michael J Fisher
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus. Neuro-oncology 24 (11) (2022)
Iris Li, Iris R Hartley, Joanna Klubo-Gwiedzdzinska, James C Reynolds, Barbara J Thomas, Julie Hogan, Mahider M Enyew, Eva Dombi, Alexander Ling, Srivandana Akshintala, David J Venzon, Jaydira Del Rivero, Michael Collins, John W Glod
Fracture Risk in Pediatric Patients With MEN2B. The Journal of clinical endocrinology and metabolism 107 (12) (2022)
Catherine Lai, Diane Cole, Seth M Steinberg, Andrea Nicole Lucas, Eva Dombi, Christopher Melani, Mark J Roschewski, Frank M Balis, Brigitte C Widemann, Wyndham H Wilson
Doxorubicin Pharmacokinetics and Toxicity in Patients with Aggressive Lymphoma and Hepatic Impairment. Blood advances (2022)
Michael J Fisher, Jaishri O Blakely, Brian D Weiss, Eva Dombi, Shivani Ahlawat, Srivandana Akshintala, Allan J Belzberg, Miriam Bornhorst, Miriam A Bredella, Wenli Cai, Rosalie E Ferner, Andrea M Gross, Gordon J Harris, Robert Listernick, Ina Ly, Staci Martin, Victor F Mautner, Johannes M Salamon, Kilian E Salerno, Robert J Spinner, Verena Staedtke, Nicole J Ullrich, Meena Upadhyaya, Pamela L Wolters, Kaleb Yohay, Brigitte C Widemann
Management of neurofibromatosis type 1-associated plexiform neurofibromas. Neuro-oncology 24 (11) (2022)
Andrea M Gross, Brittany Glassberg, Pamela L Wolters, Eva Dombi, Andrea Baldwin, Michael J Fisher, Ae Rang Kim, Miriam Bornhorst, Brian D Weiss, Jaishri O Blakely, Patricia Whitcomb, Scott M Paul, Seth M Steinberg, David J Venzon, Staci Martin, Amanda Carbonell, Kara Heisey, Janet Therrien, Oxana Kapustina, Anne Dufek, Joanne Derdak, Malcolm A Smith, Brigitte C Widemann
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity. Neuro-oncology 24 (11) (2022)
John A Ligon, R Taylor Sundby, Mary Frances Wedekind Malone, Fernanda I Arnaldez, Jaydira Del Rivero, Lori S Wiener, Ramaprasad Srinivasan, Melissa Spencer, Amanda Carbonell, Haiyan Lei, Jack F Shern, Seth M Steinberg, William Douglas Figg, Cody J Peer, Sara M Zimmerman, Josquin Moraly, Xia Xu, Stephen Fox, King Chan, Michael I Barbato, Thorkell Andresson, Naomi Taylor, Karel Pacak, J Keith Killian, Eva Dombi, W Marston Linehan, Markku M Miettinen, Richard L Piekarz, Lee J Helman, Paul S Meltzer, Brigitte C Widemann, John W Glod
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-associated Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Brian D Weiss, Pamela L Wolters, Scott R Plotkin, Brigitte C Widemann, James H Tonsgard, Jaishri O Blakely, Jeffrey C Allen, Elizabeth K Schorry, Bruce R Korf, Nathan J Robison, Stewart Goldman, Alexander A Vinks, Chie Emoto, Tsuyoshi Fukuda, Coretta T Robinson, Gary R Cutter, Lloyd J Edwards, Eva Dombi, Nancy Ratner, Roger Packer, Michael J Fisher
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2021)
Shivani Ahlawat, K Ina Ly, Laura M Fayad, Michael J Fisher, Andrés J Lessing, Dale J Berg, Johannes M Salamon, Victor-Felix Mautner, Dusica Babovic-Vuksanovic, Eva Dombi, Gordon Harris, Scott R Plotkin, Jaishri Blakeley, null null
Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment. Neurology 97 (7 Suppl 1) (2021)
Caitlin Tydings, Pavel Yarmolenko, Miriam Bornhorst, Eva Dombi, John Myseros, Robert Keating, James Bost, Karun Sharma, AeRang Kim
Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1. Neuro-oncology advances 3 (1) (2021)
Lauren H Boal, John Glod, Melissa Spencer, Miki Kasai, Joanne Derdak, Eva Dombi, Mark Ahlman, Daniel W Beury, Melinda S Merchant, Christianne Persenaire, David J Liewehr, Seth M Steinberg, Brigitte C Widemann, Rosandra N Kaplan
Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform Neurofibromas. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Katherine E Chaney, Melissa R Perrino, Leah J Kershner, Ami V Patel, Jianqiang Wu, Kwangmin Choi, Tilat A Rizvi, Eva Dombi, Sara Szabo, David A Largaespada, Nancy Ratner
Cdkn2a Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST. Cancer research 80 (21) (2020)
Sadhana Jackson, Eva H Baker, Andrea M Gross, Patricia Whitcomb, Andrea Baldwin, Joanne Derdak, Cecilia Tibery, Jennifer Desanto, Amanda Carbonell, Kaleb Yohay, Geraldine O'Sullivan, Alice P Chen, Brigitte C Widemann, Eva Dombi
The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas. Neuro-oncology advances 2 (1) (2020)

Eva Dombi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Eva Dombi